← Leaderboards
Hua Zhao
Roswell Park Cancer Institute Corp
$6,386,020
Attributed
$12,329,519
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,329,519 · 11
By mechanism
R01$7,590,431 · 2
U01$2,800,443 · 2
R21$1,059,442 · 3
P01$583,666 · 1
R03$291,994 · 2
P20$3,543 · 1
Top collaborators
- Song Liu6 shared
- Lisa A. Cannon Albright5 shared
- Chad Daniel Huff5 shared
- Qianqian Zhu4 shared
- Jie Shen2 shared
- Lisa Sale Shock2 shared
- Christopher Ryan Miller1 shared
Most similar at Roswell Park Cancer Institute Corp
Same institution · by research overlap
- Christine B. Ambrosone$40,409,261
- Andrew Olshan$2,560,620
Others in their field
Top investigators on “Malignant Breast Neoplasm”
- David Heimbrook · Leidos Biomedical Research, Inc.$347,312,063
- Norman Wolmark · Nsabp Foundation, Inc.$122,067,540
- Walter John Curran · Thomas Jefferson University$97,002,422
- Monica M Bertagnolli · Strang Cancer Prevention Center$84,975,759
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$68,847,428
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$60,763,376
Research focus
Malignant Breast NeoplasmMalignant NeoplasmsBaseGeneticWomanSamplingDiagnosisBreast Cancer Risk FactorMutationPreventionTumorAllelesVariantPredispositionInnovationTissuesInsightGenesHigh RiskCarcinogenesisCancer RiskEpidemiologyCancer-Predisposing GeneCase Control
Grant awards (27)
Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor$952,237
U01 · FY2025 · CA · contact PI
Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor$484,154
U01 · FY2024 · CA · contact PI
Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor$522,328
U01 · FY2023 · CA · contact PI
Mitochondrial dysfunction and chronic stress intersect as mechanisms driving breast cancer racial disparities$177,820
R21 · FY2023 · CA
Homologous recombination repair capacity in peripheral blood lymphocytes as a breast cancer risk factor$512,284
U01 · FY2022 · CA · contact PI
Mitochondrial dysfunction and chronic stress intersect as mechanisms driving breast cancer racial disparities$217,738
R21 · FY2022 · CA
High-throughput sequencing to identify novel melanoma susceptibility genes$1,036,661
R01 · FY2019 · CA
High-throughput sequencing to identify novel melanoma susceptibility genes$1,075,363
R01 · FY2018 · CA
Pilot Project 1: Mexican immigrants' biological and behavioral cancer risk based on stress$3,543
P20 · FY2018 · CA · contact PI
High-throughput sequencing to identify novel melanoma susceptibility genes$1,075,388
R01 · FY2017 · CA
Racial/ethnic disparity in breast cancer: can metabolic profiles play a role?$329,440
U01 · FY2017 · CA · contact PI
High-throughput sequencing to identify novel melanoma susceptibility genes$1,075,017
R01 · FY2016 · CA
High-throughput sequencing to identify novel melanoma susceptibility genes$1,090,017
R01 · FY2015 · CA
Mitochondrial DNA heteroplasmy and breast cancer risk$74,260
R03 · FY2013 · CA
MIcroRNA: A Novel Genetic Modifier for Breast Cancer Predisposition$475,640
R01 · FY2012 · CA · contact PI
Sequencing to Identify Novel Breast Cancer Risk Factors in African American Women$151,369
R21 · FY2012 · CA
Mitochondrial DNA heteroplasmy and breast cancer risk$79,000
R03 · FY2012 · CA
Biospecimen: Genomics and Pathology$583,666
P01 · FY2011 · CA · contact PI
MIcroRNA: A Novel Genetic Modifier for Breast Cancer Predisposition$562,049
R01 · FY2011 · CA · contact PI
Sequencing to identify novel breast cancer risk factors in African American women$171,879
R21 · FY2011 · CA
Mitochondrial: A Novel genetic modifier for breast cancer risk in Caucasian and A$97,188
R21 · FY2011 · CA · contact PI
Mitochondrial: A Novel genetic modifier for breast cancer risk in Caucasian and A$63,200
R21 · FY2011 · CA · contact PI
MIcroRNA: A Novel Genetic Modifier for Breast Cancer Predisposition$621,709
R01 · FY2010 · CA · contact PI
Mitochondrial: A Novel genetic modifier for breast cancer risk in Caucasian and A$180,248
R21 · FY2010 · CA · contact PI
MIcroRNA: A Novel Genetic Modifier for Breast Cancer Predisposition$578,587
R01 · FY2009 · CA · contact PI
DNA Repair Capacity and Risk of Pre-malignant Lesion in Lung Epithelium$69,653
R03 · FY2009 · CA · contact PI
DNA Repair Capacity and Risk of Pre-malignant Lesion in Lung Epithelium$69,081
R03 · FY2008 · CA · contact PI